BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14746327)

  • 21. Recall of women in a cervical cytology screening programme. An estimate of the true rate of response.
    Sansom CD; MacInerney J; Oliver V; Wakefield J; Yule R
    Br J Prev Soc Med; 1975 Jun; 29(2):131-4. PubMed ID: 1182355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical cancer screening in England.
    Patnick J
    Eur J Cancer; 2000 Nov; 36(17):2205-8. PubMed ID: 11072205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomised controlled trial of methods of call and recall for cervical cytology screening.
    Pierce M; Lundy S; Palanisamy A; Winning S; King J
    BMJ; 1989 Jul; 299(6692):160-2. PubMed ID: 2504359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quality of smear taking training for hospital medical trainees.
    Mokate T; Abidogun K; Watson AJ
    Cytopathology; 2006 Dec; 17(6):361-5. PubMed ID: 17168919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased uptake of cervical screening by women with HIV infection in Auckland regardless of ethnicity, requirement for an interpreter or level of education.
    Lowe M; Handy R; Ingram J; Nisbet M; Ritchie S; Thomas M; Briggs S
    N Z Med J; 2016 Jul; 129(1438):22-31. PubMed ID: 27447132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing the uptake of cervical smears: strategies implemented among general practitioners in Auckland.
    White GE; McAvoy BR; Gleisner S
    N Z Med J; 1993 Aug; 106(962):357-60. PubMed ID: 8255562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
    Jensen H; Svanholm H; Støvring H; Bro F
    J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General practitioner based screening for cervical cancer: higher participation of women with a higher risk?
    Kant AC; Palm BT; Wentink E; van Weel C
    J Med Screen; 1997; 4(1):35-9. PubMed ID: 9200061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Participation in the Dutch national screening programme for uterine cervic cancer higher after invitation by a general practitioner, especially in groups with a traditional low level of attendance].
    de Nooijer DP; de Waart FG; van Leeuwen AW; Spijker WW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2339-43. PubMed ID: 16261714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary results of a general practice based call system for cervical cancer screening in The Netherlands.
    Palm BT; Kant AC; van den Bosch WJ; Vooijs GP; van Weel C
    Br J Gen Pract; 1993 Dec; 43(377):503-6. PubMed ID: 8312021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population-based study of primary care predictors of non-attendance for cervical screening.
    Webb R; Richardson J; Pickles A
    J Med Screen; 2004; 11(3):135-40. PubMed ID: 15333272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the offer of cervical screening with breast screening encourage older women to have a cervical smear test?
    Lancaster G; Elton P
    J Epidemiol Community Health; 1992 Oct; 46(5):523-7. PubMed ID: 1479324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden.
    Eaker S; Adami HO; Sparén P
    Prev Med; 2001 Jun; 32(6):482-91. PubMed ID: 11394952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical cancer screening: women's knowledge, attitudes and preferences.
    Nicoll PM; Narayan KV; Paterson JG
    Health Bull (Edinb); 1991 May; 49(3):184-90. PubMed ID: 1917453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.
    Sasieni PD; Cuzick J; Lynch-Farmery E
    Br J Cancer; 1996 Apr; 73(8):1001-5. PubMed ID: 8611418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cytology in the Vale of Trent faculty of the Royal College of General Practitioners, 1985-8.
    Wilson A
    BMJ; 1990 Feb; 300(6721):376-8. PubMed ID: 2106993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Questionnaire survey of women aged 56-59 years: consultations in general practice, use of hormone replacement therapy (HRT) and participation in screening programmes.
    Seamark C; Blake S
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):15-7. PubMed ID: 16259809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of a national Family Health Services Authority based cervical cytology system.
    Amery J; Beardow R; Oerton J; Victor C
    Health Trends; 1992; 24(4):119-22. PubMed ID: 10123981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.